Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK4 | P11802 | 6/20 | 0.46 |
| ▸ | CCND1 | P24385 | 6/20 | 0.46 |
| ▸ | CDK1 | P06493 | 5/20 | 0.46 |
| ▸ | CCNB1 | P14635 | 5/20 | 0.46 |
| ▸ | CCNA2 | P20248 | 3/20 | 0.46 |
| ▸ | CDK2 | P24941 | 3/20 | 0.46 |
| ▸ | CCNA1 | P78396 | 3/20 | 0.46 |
| ▸ | BTK | Q06187 | 14/20 | 0.43 |
| ▸ | CDK6 | Q00534 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22650363 | 0.92 | BTK (0.44) | CDK4CCND1CDK1CCNB1CCNA2 | |
| SCHEMBL22650361 | 0.84 | BTK (0.40) | CDK4CCND1CDK1CCNB1CCNA2 | |
| SCHEMBL22650569 | 0.84 | CDK4 (0.43) | CDK4CCND1CDK1CCNB1CCNA2 | |
| SCHEMBL22650594 | 0.83 | CDK4 (0.42) | CDK4CCND1CDK1CCNB1CCNA2 | |
| SCHEMBL29491175 | 0.83 | CDK4 (0.49) | CDK4CCND1CDK1CCNB1CCNA2 | |
| SCHEMBL22650846 | 0.83 | CDK4 (0.42) | CDK4CCND1CDK1CCNB1CCNA2 | |
| SCHEMBL22650568 | 0.83 | CDK4 (0.49) | CDK4CCND1CDK1CCNB1CCNA2 | |
| SCHEMBL22650924 | 0.83 | CDK4 (0.48) | CDK4CCND1CDK1CCNB1CCNA2 | |
| SCHEMBL22650755 | 0.82 | CDK4 (0.42) | CDK4CCND1CDK1CCNB1CCNA2 | |
| SCHEMBL22650719 | 0.82 | CDK4 (0.41) | CDK4CCND1CDK1CCNB1CCNA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020224568-A1 | CDK INHIBITORS | QILU REGOR THERAPEUTICS INC. (CN) | 2020-11-12 | — | — | WO | disclosed |